Levenue 500 Tablet contains Levetiracetam 500mg, an antiepileptic medication used primarily for the treatment of partial-onset seizures, myoclonic seizures, and generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby inhibiting abnormal neuronal firing and reducing seizure activity. This medication is indicated as adjunctive therapy in adults and pediatric patients aged one month and older. Levenue 500 Tablet is generally well-tolerated, with common adverse effects including somnolence, dizziness, headache, and fatigue. It is important to monitor patients for behavioral changes, mood alterations, or signs of depression, as these have been reported in some cases. Dosage should be individualized based on clinical response and renal function, with gradual titration recommended to minimize side effects. Caution is advised when used concomitantly with other central nervous system depressants. Levenue 500 Tablet should be administered under medical supervision, and patients should be advised not to discontinue therapy abruptly to avoid increased seizure risk. Regular follow-up and adherence to prescribed dosing are critical to achieving optimal therapeutic outcomes in epilepsy management.